Skip to main content

Peer Review reports

From: Bioequivalence trials for the approval of generic drugs in Saudi Arabia: a descriptive analysis of design aspects

Original Submission
29 Nov 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Dec 2023 Reviewed Reviewer Report - Krishnamurthy Bhat
20 Jan 2024 Reviewed Reviewer Report
25 Feb 2024 Reviewed Reviewer Report
10 Mar 2024 Author responded Author comments - Turki A. Althunian
Resubmission - Version 3
10 Mar 2024 Submitted Manuscript version 3
12 Mar 2024 Author responded Author comments - Turki A. Althunian
Resubmission - Version 4
12 Mar 2024 Submitted Manuscript version 4
13 Mar 2024 Reviewed Reviewer Report
21 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
22 Mar 2024 Editorially accepted
5 Apr 2024 Article published 10.1186/s12874-024-02207-4

You can find further information about peer review here.

Back to article page